Literature DB >> 2864881

Acute stress ulceration.

K Hillman.   

Abstract

Stress ulceration is usually considered a mucosal abnormality of the oesophagus, stomach or duodenum in the critically ill. It is found to a varying degree in all such patients. Only about one-quarter of lesions are associated with blood loss and less than 5% need resuscitation and treatment. However, because treatment of established bleeding is unsatisfactory, and associated with a high mortality, prophylactic measures are usually employed. These include optimising gastric mucosal blood flow and oxygen delivery, correcting coagulation abnormalities and treating underlying infection. Enteral feeding should also be employed whenever possible. Other prophylactic measures currently used involve raising gastric pH above 4, with either antacids or H2 receptor antagonists. This is best achieved by measuring the gastric pH hourly and titrating it against an appropriate dose of either type of drug or a combination of both. Newer drugs, such as omeprazole, sucralfate and prostaglandins, are proving very successful in the treatment and prevention of gastric and duodenal ulcers and may prove even more effective than currently available agents.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2864881     DOI: 10.1177/0310057X8501300302

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  3 in total

1.  Pattern of 72-hour intragastric acidity in a homogeneous group of intensive care unit patients.

Authors:  W P Geus; S J Smith; J A De Haas; C B Lamers
Journal:  Dig Dis Sci       Date:  1994-08       Impact factor: 3.199

2.  Effect of ranitidine on intragastric pH and stress-related upper gastrointestinal bleeding in patients with severe head injury.

Authors:  P Burgess; G M Larson; P Davidson; J Brown; C A Metz
Journal:  Dig Dis Sci       Date:  1995-03       Impact factor: 3.199

Review 3.  Helicobacter pylori in intensive care: why we should be interested.

Authors:  Megan S Robertson; Robert L Clancy; John F Cade
Journal:  Intensive Care Med       Date:  2003-08-28       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.